Showing results (241-250 of 330) with videos related to
Sort By:
Pageof 33
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 30, 2004
Association between the glutathione S-transferase M1 gene deletion and female methamphetamine abusersHiroki Koizumi, Kenji Hashimoto, Chikara Kumakiri, et al.International Clinical Psychopharmacology|September 2, 2020
The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open studyNobuhisa Kanahara, Masayuki Takase, Tsuyoshi Sasaki, et al.Plos One|August 11, 2012
Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorderTaisuke Yoshida, Masatomo Ishikawa, Tomihisa Niitsu, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 2, 2004
Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in JapanKanako Itoh, Kenji Hashimoto, Eiji Shimizu, et al.Current Neuropharmacology|September 3, 2011
Association Analysis of Nuclear Receptor Rev-erb Alpha Gene (NR1D1) and Japanese Methamphetamine DependenceTaro Kishi, Tsuyoshi Kitajima, Kunihiro Kawashima, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 11, 2008
Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese populationTasuku Hashimoto, Kenji Hashimoto, Ryosuke Miyatake, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 22, 2007
Deficits in auditory P50 inhibition in obsessive-compulsive disorderTasuku Hashimoto, Eiji Shimizu, Kaori Koike, et al.BMC Research Notes|March 2, 2013
A preliminary study of individual cognitive behavior therapy for social anxiety disorder in Japanese clinical settings: a single-arm, uncontrolled trialNaoki Yoshinaga, Fumiyo Ohshima, Satoshi Matsuki, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|May 9, 2015
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trialTsuyoshi Miyaoka, Motohide Furuya, Jun Horiguchi, et al.Annals of General Psychiatry|June 25, 2010
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophreniaAkihiro Shiina, Yukihiko Shirayama, Tomihisa Niitsu, et al.Pageof 33